Choosing between lab equipment financing routes: what a lease, a loan and an outright purchase each do to cash, to ownership and to what happens at the end of the term, why service, lab consumables and the rest of the recurring bill belong in the comparison rather than in a separate budget, and the clauses that decide whether a lease is a good one
Laboratory instruments are bought with a capital budget that arrives once and consumed by running costs that arrive every year, which is why financing is worth thinking about rather than defaulting to. The comparison only works if service, consumables and the end of term are in it, and those are exactly what a headline monthly figure leaves out.
- the horizon a financing comparison has to cover to be honest
- 5 years
- where lease costs hide, in return condition and renewal
- end of term
- the accreditation whose calibration obligations follow the instrument
- ISO 17025
Figures in this panel are the standards and conventions the equipment is specified and operated against, linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an equipment price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Comparing the routes properly
- Understand what each route does to ownership. An outright purchase gives you the asset and the residual value. A finance lease is a purchase spread over time and usually ends in ownership. An operating lease is a rental where the provider keeps the asset and takes the residual risk. Those are three different things and only the third protects you from obsolescence.
- Put service and consumables in the comparison. On most instruments the five year service and consumable bill exceeds the purchase price, and proprietary consumables are where a cheap instrument becomes expensive. Compare total cost over a realistic life, not the acquisition figure.
- Read what happens at the end of the term. Return condition requirements, refurbishment charges, automatic renewal clauses and the buyout figure are where lease costs hide. A return condition you cannot meet turns a clean exit into a bill.
- Check who carries the risk of failure and obsolescence. A lease that continues whatever happens to the instrument leaves you paying for a broken asset. Ask specifically what happens if the instrument fails, is superseded, or the vendor stops supporting it.
- Decide from the instrument's likely life, not the cash flow. Instruments that will be used for a decade suit purchase; those in a fast-moving area, or needed for a fixed-term project, suit an operating lease. Letting cash flow alone decide is how a laboratory ends up renting something it should have bought.
What financing does not change
Calibration, qualification and service obligations follow the instrument regardless of who owns it, and an accredited laboratory owes them on a leased instrument exactly as on a purchased one. Check the lease permits the service arrangement your accreditation requires.
Siting, power and extraction are the same problem either way, and they are frequently the real constraint. Financing solves a cash problem and not a building one.
Grants, shared facilities and the alternatives
For intermittent use, core facility access is usually cheaper than any financing route and comes with an expert. The honest comparison for a specialised instrument is ownership against hourly access rather than lease against purchase.
Where a grant funds capital but not running costs, an instrument with expensive proprietary consumables is a liability the grant does not cover. That mismatch is worth modelling before the application rather than after the award.
Common questions
- Lease or buy laboratory equipment?
- Buy what you will use for a decade and can service; lease what will be superseded or is needed for a fixed term. The decision follows from the instrument's useful life rather than from the monthly figure.
- What does a headline monthly figure leave out?
- Service, consumables, insurance, the end of term condition and any buyout. On most instruments the running costs exceed the capital cost over five years, so a comparison without them is not a comparison.
- What clauses matter most in a lease?
- Return condition and refurbishment charges, automatic renewal, the buyout figure, and what happens if the instrument fails or is discontinued. Those four decide whether a lease ends cleanly.
- Is refurbished equipment worth considering?
- For mechanically simple items with a warranty and a service history, frequently yes. For anything with optics, detectors or a regulated role, the service history and parts availability matter more than the saving.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/lab-equipment-financing/.